107189-01-5

Upstream product

• 107189-00-4 2-(5-Bromo-2,3-dimethoxyphenyl)-4,5-dihydro-4,4-dimethyloxazole 
• 75-03-6 ethyl iodide 
• 110582-83-7 2,3-Dimethoxy-5-ethylbenzoyl chloride 
• 124-68-5 2-Amino-2-methyl-1-propanol 
• 107189-05-9 2,3-dimethoxy-5-ethyl benzoic acid 
• 107188-91-0 5-bromo-2,3-dimethoxybenzoic acid chloride 
• 129117-51-7 5-Bromo-N-(2-hydroxy-1,1-dimethylethyl)-2,3-dimethoxybenzamid 
• 72517-23-8 5-bromo-2,3-dimethoxybenzoic acid 
• 110582-82-6 2,3-dimethoxy-5-ethenyl benzoic acid 
• 6948-30-7 5-bromoveratralaldehyde 
• 5293-42-5 1-bromo-2,3-dimethoxy-5-ethenyl benzene 
• 2973-76-4 5-bromo-4-hydroxy-3-methoxybenzaldehyde 

Downstream Products

• 110582-84-8 2-<4'-ethyl-2'-methoxy-1'-<2-(1,4,5-trimethoxynaphthalene)>phenyl>-4,4-dimethyl-2,3-dihydro-oxazole 
• 107189-05-9 2,3-dimethoxy-5-ethyl benzoic acid 
• 80155-95-9 defucogilvocarcin V 
• 110582-83-7 2,3-Dimethoxy-5-ethylbenzoyl chloride 
• 107188-77-2 5-Ethyl-N-((S)-1-ethyl-pyrrolidin-2-ylmethyl)-2,3-dimethoxy-benzamide 

Relevant academic research and scientific papers

Total synthesis of the ravidomycin aglycone (defucogilvocarcin V)

The synthesis of 1-hydroxy-10,12-dimethoxy-8-vinyl-6H-benzonaphtho-pyran-6-one 7, starting from vanillin and 1,5-dihydroxynaphthalene is described.This compound is the aglycone of the antitumor antibiotic ravidomycin and is identical with the recently reported antimicrobial agent, defucogilcocarcin V.